Welcome to the Newsroom
06 July 2017
SYDNEY, AUSTRALIA - Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD) (“Prima” or the
“Company”) announced that it has issued 2,631,268 of its NASDAQ listed American Depositary Shares (“ADSs”) at a purchase price per ADS of US$1.90 issue and unregistered warrants to purchase up to 1,973,451 of its ADSs to accredited investors. The warrants have an exercise price of US$2.50 per ADS, are exercisable immediately and will expire 5.5 years from the date of issuance.
Article as pdf